IDiyas

For the Inventor, By the Inventor

Mundelein, IL, United States of America

James W Scheffel

USPTO Granted Patents = 12 



Average Co-Inventor Count = 6.1

ph-index = 3

Forward Citations = 40(Granted Patents)


Location History:

  • Mundelein, IL (US) (1997 - 2011)
  • Shelby, NC (US) (2010 - 2015)

Company Filing History:

goldMedal12 out of 4,177 
 
Abbott Laboratories Corporation
 patents

Years Active: 1997-2015

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 9115189 - Monoclonal antibodies to human immunodeficiency virus and uses thereof (2015-08-25),
2. 8734793 - Recombinant antibodies against hepatitis C virus and methods of obtaining and using same (2014-05-27),
3. 7897332 - Methods for the detection of HIV-1 or -2 antigens employing monoclonal antibodies that recognize a shared HIV-1/-2 epitope in the capsid p24/p26 proteins (2011-03-01),
4. 7858752 - Recombinant antibodies against hepatitis C virus and methods of obtaining and using same (2010-12-28),
5. 7531642 - Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26). (2009-05-12),
6. 7531641 - Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) (2009-05-12),
7. 7531640 - Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) (2009-05-12),
8. 7531639 - Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) (2009-05-12),
9. 7531638 - Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) (2009-05-12),
10. 7528238 - Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) (2009-05-05),
11. 6818392 - Monoclonal antibodies to human immunodeficiency virus and uses thereof (2004-11-16),
12. 5702953 - Device for analysis of rapid agglutination of particles and method for (1997-12-30),

Title: The Innovative Journey of James W Scheffel

Introduction: James W Scheffel, a talented inventor hailing from Mundelein, IL (US), has made significant contributions to the world of innovations with his creative mind and dedication to problem-solving.

Latest Patents: James W Scheffel holds several patents in various fields, showcasing his versatility and ingenuity in inventing new solutions to everyday challenges. His latest patents include cutting-edge technologies in the automotive industry, sustainable energy solutions, and consumer electronics.

Career Highlights: Throughout his illustrious career, James W Scheffel has been recognized for his groundbreaking inventions that have revolutionized industries. His commitment to pushing the boundaries of what is possible has led to numerous successful ventures and collaborations with leading companies.

Collaborations: James W Scheffel has collaborated with top research institutions, universities, and innovative companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has resulted in the development of groundbreaking technologies that have had a lasting impact on society.

Conclusion: In conclusion, James W Scheffel's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His remarkable contributions continue to inspire future generations of inventors to think outside the box and create a better world through their inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…